Logo image of A

AGILENT TECHNOLOGIES INC (A) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:A - US00846U1016 - Common Stock

138.325 USD
-0.2 (-0.14%)
Last: 12/23/2025, 11:35:03 AM
Fundamental Rating

6

Overall A gets a fundamental rating of 6 out of 10. We evaluated A against 57 industry peers in the Life Sciences Tools & Services industry. While A has a great profitability rating, there are some minor concerns on its financial health. A is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

A had positive earnings in the past year.
A had a positive operating cash flow in the past year.
In the past 5 years A has always been profitable.
Of the past 5 years A 4 years had a positive operating cash flow.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

A's Return On Assets of 9.98% is amongst the best of the industry. A outperforms 89.47% of its industry peers.
With an excellent Return On Equity value of 19.15%, A belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
A's Return On Invested Capital of 12.86% is amongst the best of the industry. A outperforms 87.72% of its industry peers.
Industry RankSector Rank
ROA 9.98%
ROE 19.15%
ROIC 12.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 17.97%, A belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
A's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 22.44%, A belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
A's Operating Margin has improved in the last couple of years.
The Gross Margin of A (52.92%) is better than 64.91% of its industry peers.
In the last couple of years the Gross Margin of A has remained more or less at the same level.
Industry RankSector Rank
OM 22.44%
PM (TTM) 17.97%
GM 52.92%
OM growth 3Y-3.42%
OM growth 5Y5.78%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1.19%
GM growth 5Y-0.27%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

A has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
A has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

A has an Altman-Z score of 5.35. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of A (5.35) is better than 84.21% of its industry peers.
A has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as A would need 3.13 years to pay back of all of its debts.
The Debt to FCF ratio of A (3.13) is better than 82.46% of its industry peers.
A has a Debt/Equity ratio of 0.54. This is a neutral value indicating A is somewhat dependend on debt financing.
A has a Debt to Equity ratio of 0.54. This is in the lower half of the industry: A underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.13
Altman-Z 5.35
ROIC/WACC1.2
WACC10.68%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A has a Current Ratio of 2.25. This indicates that A is financially healthy and has no problem in meeting its short term obligations.
A has a Current ratio of 2.25. This is comparable to the rest of the industry: A outperforms 43.86% of its industry peers.
A Quick Ratio of 1.71 indicates that A should not have too much problems paying its short term obligations.
A has a Quick ratio (1.71) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.71
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

A shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.48%.
A shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.21% yearly.
Looking at the last year, A shows a small growth in Revenue. The Revenue has grown by 6.73% in the last year.
Measured over the past years, A shows a small growth in Revenue. The Revenue has been growing by 5.41% on average per year.
EPS 1Y (TTM)5.48%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%8.9%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%9.41%

3.2 Future

The Earnings Per Share is expected to grow by 9.88% on average over the next years. This is quite good.
A is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.77% yearly.
EPS Next Y8.47%
EPS Next 2Y9.32%
EPS Next 3Y10.13%
EPS Next 5Y9.88%
Revenue Next Year6.38%
Revenue Next 2Y6.33%
Revenue Next 3Y6.42%
Revenue Next 5Y5.77%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.79, which indicates a rather expensive current valuation of A.
Compared to the rest of the industry, the Price/Earnings ratio of A indicates a rather cheap valuation: A is cheaper than 80.70% of the companies listed in the same industry.
A's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.61.
A is valuated rather expensively with a Price/Forward Earnings ratio of 22.85.
Based on the Price/Forward Earnings ratio, A is valued cheaper than 80.70% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of A to the average of the S&P500 Index (24.01), we can say A is valued inline with the index average.
Industry RankSector Rank
PE 24.79
Fwd PE 22.85
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, A is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of A indicates a somewhat cheap valuation: A is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.04
EV/EBITDA 22.71
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
A has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.93
PEG (5Y)2.21
EPS Next 2Y9.32%
EPS Next 3Y10.13%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.75%, A is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.09, A pays a better dividend. On top of this A pays more dividend than 98.25% of the companies listed in the same industry.
With a Dividend Yield of 0.75, A pays less dividend than the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 0.75%

5.2 History

On average, the dividend of A grows each year by 7.63%, which is quite nice.
A has paid a dividend for at least 10 years, which is a reliable track record.
A has decreased its dividend recently.
Dividend Growth(5Y)7.63%
Div Incr Years1
Div Non Decr Years1
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

22.95% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
A's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.95%
EPS Next 2Y9.32%
EPS Next 3Y10.13%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

AGILENT TECHNOLOGIES INC

NYSE:A (12/23/2025, 11:35:03 AM)

138.325

-0.2 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-24 2025-11-24/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners92.13%
Inst Owner Change-0.44%
Ins Owners0.16%
Ins Owner Change3.19%
Market Cap39.22B
Revenue(TTM)6.95B
Net Income(TTM)1.22B
Analysts76.92
Price Target170.67 (23.38%)
Short Float %1.16%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0.75%
Yearly Dividend0.95
Dividend Growth(5Y)7.63%
DP22.95%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-06 2026-01-06 (0.255)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.04%
Min EPS beat(2)-1.64%
Max EPS beat(2)1.56%
EPS beat(4)3
Avg EPS beat(4)0.66%
Min EPS beat(4)-1.64%
Max EPS beat(4)1.57%
EPS beat(8)7
Avg EPS beat(8)1.26%
EPS beat(12)10
Avg EPS beat(12)1.89%
EPS beat(16)13
Avg EPS beat(16)2.06%
Revenue beat(2)2
Avg Revenue beat(2)1.42%
Min Revenue beat(2)0.54%
Max Revenue beat(2)2.3%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.06%
Revenue beat(12)6
Avg Revenue beat(12)0.29%
Revenue beat(16)7
Avg Revenue beat(16)0.09%
PT rev (1m)12.14%
PT rev (3m)24.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.09%
EPS NY rev (1m)-1.4%
EPS NY rev (3m)-1.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 24.79
Fwd PE 22.85
P/S 5.78
P/FCF 36.04
P/OCF 26.23
P/B 6.16
P/tB 27.5
EV/EBITDA 22.71
EPS(TTM)5.58
EY4.03%
EPS(NY)6.05
Fwd EY4.38%
FCF(TTM)3.84
FCFY2.77%
OCF(TTM)5.27
OCFY3.81%
SpS23.94
BVpS22.47
TBVpS5.03
PEG (NY)2.93
PEG (5Y)2.21
Graham Number53.11
Profitability
Industry RankSector Rank
ROA 9.98%
ROE 19.15%
ROCE 14.74%
ROIC 12.86%
ROICexc 15.09%
ROICexgc 34.15%
OM 22.44%
PM (TTM) 17.97%
GM 52.92%
FCFM 16.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.42%
OM growth 5Y5.78%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1.19%
GM growth 5Y-0.27%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.13
Debt/EBITDA 1.88
Cap/Depr 142.31%
Cap/Sales 6%
Interest Coverage 17.92
Cash Conversion 82.64%
Profit Quality 89.18%
Current Ratio 2.25
Quick Ratio 1.71
Altman-Z 5.35
F-Score7
WACC10.68%
ROIC/WACC1.2
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.48%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%8.9%
EPS Next Y8.47%
EPS Next 2Y9.32%
EPS Next 3Y10.13%
EPS Next 5Y9.88%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%9.41%
Revenue Next Year6.38%
Revenue Next 2Y6.33%
Revenue Next 3Y6.42%
Revenue Next 5Y5.77%
EBIT growth 1Y-5.11%
EBIT growth 3Y-2.95%
EBIT growth 5Y11.51%
EBIT Next Year27%
EBIT Next 3Y13.98%
EBIT Next 5Y11.15%
FCF growth 1Y-23.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.29%
OCF growth 3YN/A
OCF growth 5YN/A

AGILENT TECHNOLOGIES INC / A FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to A.


What is the valuation status of AGILENT TECHNOLOGIES INC (A) stock?

ChartMill assigns a valuation rating of 5 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


Can you provide the profitability details for AGILENT TECHNOLOGIES INC?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for A stock?

The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 24.79 and the Price/Book (PB) ratio is 6.16.


What is the financial health of AGILENT TECHNOLOGIES INC (A) stock?

The financial health rating of AGILENT TECHNOLOGIES INC (A) is 6 / 10.